Sign inJoin waitlistJoin the waitlist

Lyndon Kim

Hematology & Oncology · Icahn School of Medicine at Mount Sinai

Credentials: · · · · · ·

History

The Warren Alpert Medical School Of Brown University
Massachusetts General Hospital
Brooklyn Hospital-Caledonian Hospital
Robert Wood Johnson University Hospital
Yonsei University College Of Medicine

Research

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
Journal of Clinical Oncology · 2009 · 1,277 citations
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Journal of Translational Medicine · 2018 · 425 citations
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3…
JAMA Oncology · 2023 · 399 citations

WS
Wenyin Shi
10 papers
David Andrews
9 papers
Maria Werner-Wasik
9 papers
James Evans
8 papers
Jon Glass
8 papers
Joshua Palmer
8 papers · 4 as a resident
NN
Nam Nguyen
8 papers
Brandi Page
7 papers
HG
Huan Giap
7 papers
Michael Glantz
7 papers
Santosh Kesari
7 papers
Christopher Farrell
6 papers · 6 as a resident

Clinical trials

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Site PI · Recruiting · Phase 2, Phase 3
Global Coalition for Adaptive Research
2019–2030